You are here

  • Home
  • Archive
  • Volume 99, Issue 5
  • Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study

Article info

Article menu

Download PDFPDF

Clinical science
Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study
Free

Authors

  1. Correspondence to Dr Patrick F Tzelikis, Brasilia Ophthalmologic Hospital, HOB, SQN 203, bloco K, apart 502, Brasilia, DF 70833-110, Brazil; tzelikis{at}gmail.com
View Full Text

Citation

Tzelikis PF, Vieira M, Hida WT, et al
Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study
British Journal of Ophthalmology 2015;99:654-658.

Publication history

  • Received August 15, 2014
  • Revised October 16, 2014
  • Accepted October 22, 2014
  • First published November 10, 2014.
Online issue publication 
November 28, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions